Symbol="EVOK"
AssetType="Common Stock"
Name="Evoke Pharma Inc"
Description="Evoke Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of drugs for the treatment of gastroenterological diseases and disorders. The company is headquartered in Solana Beach, California."
CIK="1403708"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="420 STEVENS AVENUE, SUITE 370, SOLANA BEACH, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="4680300"
EBITDA="None"
PERatio="None"
PEGRatio="-0.1"
BookValue="1.222"
DividendPerShare="0"
DividendYield="0"
EPS="-2.42"
RevenuePerShareTTM="0.798"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.517"
ReturnOnEquityTTM="-4.085"
RevenueTTM="2900700"
GrossProfitTTM="2138300"
DilutedEPSTTM="-2.42"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.937"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.048"
PriceToBookRatio="1.033"
EVToRevenue="0.0648"
EVToEBITDA="0.195"
Beta="0.332"
num_52WeekHigh="5.96"
num_52WeekLow="1.294"
num_50DayMovingAverage="1.605"
num_200DayMovingAverage="2.236"
SharesOutstanding="3343100"
DividendDate="None"
ExDividendDate="None"
symbol="EVOK"
open="1.34"
high="1.40"
low="1.29"
price="1.30"
volume="38550.00"
latest_trading_day="2023-08-15"
previous_close="1.36"
change="-0.06"
change_percent="-4.4118%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="97"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="3"
Volume_recent_avg="24062"
Change_recent_avg="-0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-1.16"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="3"
Aroon_momentum_negative="97"
image_negative_thumbnail_id_1="133"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0043.jpeg"
image_negative_thumbnail_id_2="108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0068.jpeg"
image_neutral_thumbnail_id_1="540"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="700"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0008.jpeg"
image_positive_thumbnail_id_2="703"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_professor_thumbnail_id_1="1169"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0003.jpeg"
image_professor_thumbnail_id_2="1175"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
